Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
GlaxoSmithKline Pharmaceuticals Limited ( (IN:GLAXO) ) has shared an update.
GlaxoSmithKline Pharmaceuticals Limited has received an order from the Bihar Central GST authorities concerning a GST credit-related issue for the fiscal year 2021-22. The order demands a total of Rs. 52,52,988, including tax and penalty, due to a mismatch between the company’s GST returns and supplier-reported details. Despite this, the company reports no impact on its financial operations and is currently evaluating the demand order to determine appropriate actions.
More about GlaxoSmithKline Pharmaceuticals Limited
GlaxoSmithKline Pharmaceuticals Limited operates in the pharmaceutical industry, focusing on the development and distribution of medicines and vaccines. The company is a key player in the healthcare sector, providing a range of pharmaceutical products to meet various medical needs.
Average Trading Volume: 2,687
Technical Sentiment Signal: Buy
Current Market Cap: 439B INR
Learn more about GLAXO stock on TipRanks’ Stock Analysis page.